Choline and contribution to normal liver function of the foetus and exclusively breastfed infants : evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
© 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority..
Following an application from Procter & Gamble BV pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to choline and contribution to normal liver function of the foetus and exclusively breastfed infant. The scope of the application was proposed to fall under a health claim referring to children's development and health. The Panel considers that choline is sufficiently characterised. The claimed effect proposed by the applicant is contribution 'to normal foetal and infant development, especially liver'. The proposed target population is 'unborn fetuses and breastfed infants'. Choline is involved in the structure of cell membranes, cell signalling, metabolism and transport of lipids and cholesterol and neurotransmitter synthesis. Although choline can be synthesised de novo by the human body, depletion-repletion studies in humans show that low choline intake leads to liver dysfunction and muscle damage, which are reverted by the administration of dietary choline. For these functions, de novo synthesis of choline by the human body is insufficient and choline must be obtained from dietary sources. No human studies have addressed the effect of low maternal dietary choline intake on liver function in the fetus or exclusively breastfed infants. However, the Panel considers that the biological role of choline in normal liver function and dietary choline being essential for the function applies to all ages, including fetus and infants. The Panel concludes that a cause and effect relationship has been established between the intake of choline by pregnant and lactating women and contribution to normal liver function of the fetus and exclusively breastfed infants.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
EFSA journal. European Food Safety Authority - 21(2023), 7 vom: 24. Juli, Seite e08115 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Choline |
|---|
| Anmerkungen: |
Date Revised 29.07.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2903/j.efsa.2023.8115 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360019323 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360019323 | ||
| 003 | DE-627 | ||
| 005 | 20231226082125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2903/j.efsa.2023.8115 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1200.xml |
| 035 | |a (DE-627)NLM360019323 | ||
| 035 | |a (NLM)37502017 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Choline and contribution to normal liver function of the foetus and exclusively breastfed infants |b evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.07.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority. | ||
| 520 | |a Following an application from Procter & Gamble BV pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to choline and contribution to normal liver function of the foetus and exclusively breastfed infant. The scope of the application was proposed to fall under a health claim referring to children's development and health. The Panel considers that choline is sufficiently characterised. The claimed effect proposed by the applicant is contribution 'to normal foetal and infant development, especially liver'. The proposed target population is 'unborn fetuses and breastfed infants'. Choline is involved in the structure of cell membranes, cell signalling, metabolism and transport of lipids and cholesterol and neurotransmitter synthesis. Although choline can be synthesised de novo by the human body, depletion-repletion studies in humans show that low choline intake leads to liver dysfunction and muscle damage, which are reverted by the administration of dietary choline. For these functions, de novo synthesis of choline by the human body is insufficient and choline must be obtained from dietary sources. No human studies have addressed the effect of low maternal dietary choline intake on liver function in the fetus or exclusively breastfed infants. However, the Panel considers that the biological role of choline in normal liver function and dietary choline being essential for the function applies to all ages, including fetus and infants. The Panel concludes that a cause and effect relationship has been established between the intake of choline by pregnant and lactating women and contribution to normal liver function of the fetus and exclusively breastfed infants | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a choline | |
| 650 | 4 | |a fetal development | |
| 650 | 4 | |a fetus | |
| 650 | 4 | |a health claims | |
| 650 | 4 | |a infants | |
| 700 | 1 | |a Turck, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Bohn, Torsten |e verfasserin |4 aut | |
| 700 | 1 | |a Castenmiller, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a De Henauw, Stefaan |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch-Ernst, Karen Ildico |e verfasserin |4 aut | |
| 700 | 1 | |a Knutsen, Helle Katrine |e verfasserin |4 aut | |
| 700 | 1 | |a Maciuk, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Mangelsdorf, Inge |e verfasserin |4 aut | |
| 700 | 1 | |a McArdle, Harry J |e verfasserin |4 aut | |
| 700 | 1 | |a Naska, Androniki |e verfasserin |4 aut | |
| 700 | 1 | |a Pentieva, Kristina |e verfasserin |4 aut | |
| 700 | 1 | |a Thies, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Tsabouri, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Vinceti, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Bresson, Jean-Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Fiolet, Thibault |e verfasserin |4 aut | |
| 700 | 1 | |a Siani, Alfonso |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EFSA journal. European Food Safety Authority |d 2004 |g 21(2023), 7 vom: 24. Juli, Seite e08115 |w (DE-627)NLM296446564 |x 1831-4732 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2023 |g number:7 |g day:24 |g month:07 |g pages:e08115 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2903/j.efsa.2023.8115 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2023 |e 7 |b 24 |c 07 |h e08115 | ||